Skip to main content
Erschienen in: Current Oncology Reports 8/2021

01.08.2021 | Palliative Medicine (A Jatoi, Section Editor)

Navigating the Cancer Screening Decision for Patients with Dementia

verfasst von: Caitlyn Kuwata, Suzanne L. Goldhirsch, Vanessa Rodríguez

Erschienen in: Current Oncology Reports | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The risks of developing cancer and dementia both increase with age, giving rise to the complex question of whether continued cancer screening for older dementia patients is appropriate. This paper offers a practice-based clinical approach to determine an answer to this challenging question.

Recent Findings

There is no consensus on the prevalence of cancer and dementia as co-diagnoses. Persons with dementia are screened less often compared to those without dementia. There is significant literature focusing on screening in the geriatric population, but there is little evidence to support decision-making for screening for older patients with dementia.

Summary

Given this lack of evidence, individualized decisions should be made in collaboration with patients and family caregivers. Four considerations to help guide this process include prognosis, behavioral constraints, cognitive capacity, and goals for care. Future research will be challenging due to variability of factors that inform screening decisions and the vulnerable nature of this patient population.
Literatur
1.
Zurück zum Zitat Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018;131(10):1161–9.CrossRef Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018;131(10):1161–9.CrossRef
3.
Zurück zum Zitat Raik BL, Miller FG, Fins JJ. Screening and cognitive impairment: ethics of forgoing mammography in older women. J Am Geriatr Soc. 2004;52(3):440–4.CrossRef Raik BL, Miller FG, Fins JJ. Screening and cognitive impairment: ethics of forgoing mammography in older women. J Am Geriatr Soc. 2004;52(3):440–4.CrossRef
4.
Zurück zum Zitat •• 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. This article summarized the current public health impact of Alzheimer’s disease in the United States and provides basic information regarding it’s epidemiology, pathology, morbidity/mortality, and the role of the caregiver. •• 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. This article summarized the current public health impact of Alzheimer’s disease in the United States and provides basic information regarding it’s epidemiology, pathology, morbidity/mortality, and the role of the caregiver.
5.
Zurück zum Zitat • McWilliams L, Farrell C, Grande G, Keady J, Swarbrick C, Yorke J. A systematic review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care. Aging Ment Health. 2018;22(10):1254–71 This article provided a review of the literature to determine the prevalence rates of cancer-dementia. This article found the rates of cancer and dementia varied from 0.2% to 45.6%.CrossRef • McWilliams L, Farrell C, Grande G, Keady J, Swarbrick C, Yorke J. A systematic review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care. Aging Ment Health. 2018;22(10):1254–71 This article provided a review of the literature to determine the prevalence rates of cancer-dementia. This article found the rates of cancer and dementia varied from 0.2% to 45.6%.CrossRef
6.
Zurück zum Zitat Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9.CrossRef Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9.CrossRef
7.
Zurück zum Zitat Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. Bmj. 2013;346:e8441.CrossRef Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. Bmj. 2013;346:e8441.CrossRef
8.
Zurück zum Zitat Morgans AK, Dale W, Briganti A. Screening and treating prostate cancer in the older patient: decision making across the clinical spectrum. Am Soc Clin Oncol Educ Book. 2017;37:370–81.CrossRef Morgans AK, Dale W, Briganti A. Screening and treating prostate cancer in the older patient: decision making across the clinical spectrum. Am Soc Clin Oncol Educ Book. 2017;37:370–81.CrossRef
9.
Zurück zum Zitat Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419–26.CrossRef Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419–26.CrossRef
10.
Zurück zum Zitat Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98.CrossRef Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98.CrossRef
11.
Zurück zum Zitat Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–30.CrossRef Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–30.CrossRef
13.
Zurück zum Zitat Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: what are the burdens? J Gen Intern Med. 2001;16(11):779–84.CrossRef Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: what are the burdens? J Gen Intern Med. 2001;16(11):779–84.CrossRef
14.
Zurück zum Zitat •• Schoenborn NL, Boyd CM, Lee SJ, Cayea D, Pollack CE. Communicating about stopping cancer screening: comparing clinicians' and older adults' perspectives. Gerontologist. 2019;59(Suppl 1):S67–s76 This article provided insight in how clinicians and patients view stopping cancer screening. Three major themes were illustrated: 1) Importance of discussing the risks/benefits and involving patients in decision making, 2) Clinicians were more concerned with patient reactions to stopping screening compared to older adults, who reported no negative reactions in the context of a trusing relationship. 3) While clinicians rarely addressed life expectancy in discussions, older adults were mixed in wanting this information as part of the discussion.CrossRef •• Schoenborn NL, Boyd CM, Lee SJ, Cayea D, Pollack CE. Communicating about stopping cancer screening: comparing clinicians' and older adults' perspectives. Gerontologist. 2019;59(Suppl 1):S67–s76 This article provided insight in how clinicians and patients view stopping cancer screening. Three major themes were illustrated: 1) Importance of discussing the risks/benefits and involving patients in decision making, 2) Clinicians were more concerned with patient reactions to stopping screening compared to older adults, who reported no negative reactions in the context of a trusing relationship. 3) While clinicians rarely addressed life expectancy in discussions, older adults were mixed in wanting this information as part of the discussion.CrossRef
15.
Zurück zum Zitat Eckstrom E, Feeny DH, Walter LC, Perdue LA, Whitlock EP. Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med. 2013;28(2):292–8.CrossRef Eckstrom E, Feeny DH, Walter LC, Perdue LA, Whitlock EP. Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med. 2013;28(2):292–8.CrossRef
16.
Zurück zum Zitat Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.CrossRef Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.CrossRef
17.
Zurück zum Zitat Siu AL. Screening for Breast Cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279–96.CrossRef Siu AL. Screening for Breast Cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279–96.CrossRef
18.
Zurück zum Zitat Practice Bulletin Number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017;130(1):e1–e16. Practice Bulletin Number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017;130(1):e1–e16.
19.
Zurück zum Zitat Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.CrossRef Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.CrossRef
20.
Zurück zum Zitat Force UPST. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.CrossRef Force UPST. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.CrossRef
21.
Zurück zum Zitat Wender R, Fontham ETH, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):106–17.CrossRef Wender R, Fontham ETH, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):106–17.CrossRef
22.
Zurück zum Zitat Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411–20.CrossRef Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411–20.CrossRef
23.
Zurück zum Zitat Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018;153(4):954–85.CrossRef Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018;153(4):954–85.CrossRef
24.
Zurück zum Zitat Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120–34.CrossRef Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120–34.CrossRef
25.
Zurück zum Zitat Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):175–204.CrossRef Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):175–204.CrossRef
26.
Zurück zum Zitat Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA. 2018;320(7):674–86.CrossRef Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA. 2018;320(7):674–86.CrossRef
27.
Zurück zum Zitat Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018;25(Suppl 1):S115–s24.CrossRef Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018;25(Suppl 1):S115–s24.CrossRef
28.
Zurück zum Zitat • Law M, Dhillon S, Herrmann N, Friesen F, Dey AK, Li A, et al. Rates of screening for breast, colorectal, and cervical cancers in older people with cognitive impairment or dementia: a meta-analysis. Gerontol Geriatr Med. 2018;4:2333721418799446 This meta-analysis found breast cancer screening occurred less frequently in those with cognitive impairement or dementia. However, there were not statistically lower in colorectal or cervical screening rates for those patients with cognitive impairement or dementia.CrossRef • Law M, Dhillon S, Herrmann N, Friesen F, Dey AK, Li A, et al. Rates of screening for breast, colorectal, and cervical cancers in older people with cognitive impairment or dementia: a meta-analysis. Gerontol Geriatr Med. 2018;4:2333721418799446 This meta-analysis found breast cancer screening occurred less frequently in those with cognitive impairement or dementia. However, there were not statistically lower in colorectal or cervical screening rates for those patients with cognitive impairement or dementia.CrossRef
29.
Zurück zum Zitat Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.CrossRef Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.CrossRef
30.
Zurück zum Zitat Mehta KM, Fung KZ, Kistler CE, Chang A, Walter LC. Impact of cognitive impairment on screening mammography use in older US women. Am J Public Health. 2010;100(10):1917–23.CrossRef Mehta KM, Fung KZ, Kistler CE, Chang A, Walter LC. Impact of cognitive impairment on screening mammography use in older US women. Am J Public Health. 2010;100(10):1917–23.CrossRef
31.
Zurück zum Zitat Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. Bmj. 2008;336(7638):258–62.CrossRef Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. Bmj. 2008;336(7638):258–62.CrossRef
32.
Zurück zum Zitat Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61(3):349–54.CrossRef Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61(3):349–54.CrossRef
33.
Zurück zum Zitat Garre-Olmo J, Ponjoan A, Inoriza JM, Blanch J, Sánchez-Pérez I, Cubí R, et al. Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study. Clin Epidemiol. 2019;11:525–42.CrossRef Garre-Olmo J, Ponjoan A, Inoriza JM, Blanch J, Sánchez-Pérez I, Cubí R, et al. Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study. Clin Epidemiol. 2019;11:525–42.CrossRef
34.
Zurück zum Zitat Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501–9.CrossRef Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501–9.CrossRef
36.
Zurück zum Zitat Ferrari C, Lombardi G, Polito C, Lucidi G, Bagnoli S, Piaceri I, et al. Alzheimer's disease progression: factors influencing cognitive decline. J Alzheimers Dis. 2018;61(2):785–91.CrossRef Ferrari C, Lombardi G, Polito C, Lucidi G, Bagnoli S, Piaceri I, et al. Alzheimer's disease progression: factors influencing cognitive decline. J Alzheimers Dis. 2018;61(2):785–91.CrossRef
37.
Zurück zum Zitat Schoenborn NL, Massare J, Park R, Boyd CM, Choi Y, Pollack CE. Assessment of clinician decision-making on cancer screening cessation in older adults with limited life expectancy. JAMA Netw Open. 2020;3(6):e206772.CrossRef Schoenborn NL, Massare J, Park R, Boyd CM, Choi Y, Pollack CE. Assessment of clinician decision-making on cancer screening cessation in older adults with limited life expectancy. JAMA Netw Open. 2020;3(6):e206772.CrossRef
38.
Zurück zum Zitat Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000;283(24):3230–5.CrossRef Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000;283(24):3230–5.CrossRef
40.
Zurück zum Zitat Halpern R, Seare J, Tong J, Hartry A, Olaoye A, Aigbogun MS. Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia. Int J Geriatr Psychiatry. 2019;34(3):420–31.CrossRef Halpern R, Seare J, Tong J, Hartry A, Olaoye A, Aigbogun MS. Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia. Int J Geriatr Psychiatry. 2019;34(3):420–31.CrossRef
41.
Zurück zum Zitat Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Caregiver perspectives on cancer screening for persons with dementia: "why put them through it?". J Am Geriatr Soc. 2013;61(8):1309–14.CrossRef Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Caregiver perspectives on cancer screening for persons with dementia: "why put them through it?". J Am Geriatr Soc. 2013;61(8):1309–14.CrossRef
42.
Zurück zum Zitat •• Martin C, Shrestha A, Burton M, Collins K, Wyld L. How are caregivers involved in treatment decision making for older people with dementia and a new diagnosis of cancer? Psychooncology. 2019;28(6):1197–206 This systematic review found that clinicians were often not aware of the co-existence of dementia in those patients with a new cancer diagnosis, which leads to unmet care needs including that primary caregivers feel excluded from decision making.CrossRef •• Martin C, Shrestha A, Burton M, Collins K, Wyld L. How are caregivers involved in treatment decision making for older people with dementia and a new diagnosis of cancer? Psychooncology. 2019;28(6):1197–206 This systematic review found that clinicians were often not aware of the co-existence of dementia in those patients with a new cancer diagnosis, which leads to unmet care needs including that primary caregivers feel excluded from decision making.CrossRef
43.
Zurück zum Zitat Balducci L, Dolan D. Palliative Care of Cancer in the Older Patient. Curr Oncol Rep. 2016;18(12):70.CrossRef Balducci L, Dolan D. Palliative Care of Cancer in the Older Patient. Curr Oncol Rep. 2016;18(12):70.CrossRef
44.
Zurück zum Zitat Daly RL, Bunn F, Goodman C. Shared decision-making for people living with dementia in extended care settings: a systematic review. BMJ Open. 2018;8(6):e018977.CrossRef Daly RL, Bunn F, Goodman C. Shared decision-making for people living with dementia in extended care settings: a systematic review. BMJ Open. 2018;8(6):e018977.CrossRef
45.
Zurück zum Zitat Saur NM, Montroni I. Geriatric Comanagement: A Secret Ingredient of the Elusive Recipe. JAMA Netw Open. 2020;3(8):e209460.CrossRef Saur NM, Montroni I. Geriatric Comanagement: A Secret Ingredient of the Elusive Recipe. JAMA Netw Open. 2020;3(8):e209460.CrossRef
Metadaten
Titel
Navigating the Cancer Screening Decision for Patients with Dementia
verfasst von
Caitlyn Kuwata
Suzanne L. Goldhirsch
Vanessa Rodríguez
Publikationsdatum
01.08.2021
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 8/2021
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-021-01083-1

Weitere Artikel der Ausgabe 8/2021

Current Oncology Reports 8/2021 Zur Ausgabe

Evolving Therapies (RM Bukowski, Section Editor)

ROS1 Targeted Therapies: Current Status

Gynecologic Cancers (J Brown and RW Naumann, Section Editors)

Progress in Gynecologic Cancers with Antibody Drug Conjugates

Gynecologic Cancers (J Brown and RW Naumann, Section Editors)

The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities

Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

Immunology of Lynch Syndrome

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.